Cargando…
Recurrent Glioblastoma: A Review of the Treatment Options
SIMPLE SUMMARY: Glioblastoma is the most common malignant brain tumor associated with a poor prognosis, with a median survival of 14 months. Despite initial treatment with surgery, radiotherapy, and chemotherapy, recurrence is the usual situation. Controversy remains over the best treatment strategy...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487236/ https://www.ncbi.nlm.nih.gov/pubmed/37686553 http://dx.doi.org/10.3390/cancers15174279 |